Stella F, Chiappella A, Magni M, Bonifazi F, et al. Brexucabtagene autoleucel in-vivo expansion and BTKi refractoriness have a negative influence on progression-free survival in mantle cell lymphoma: Results from CART-SIE study. Br J Haematol 2024 Dec 22. doi: 10.1111/bjh.19961.
PMID: 39710966